InMode Ltd.
14.79USD
-0.0200 (-0.14%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.32▼ | $0.34 | 0 | 3 |
| Next quarter | $0.38▼ | $0.41 | 0 | 4 |
| Current year | $1.3▼ | $1.32 | 1 | 3 |
| Next year | $1.37▼ | $1.48 | 0 | 4 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.33 | $0.35 | +0.02 (+5.4%) |
| 2026-03-31 | $0.3 | $0.25 | -0.05 (-16.1%) |
| 2025-12-31 | $0.42 | $0.46 | +0.04 (+10.4%) |
| 2025-09-30 | $0.35 | $0.38 | +0.03 (+7.0%) |
80 ratings from 10 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Barclays | Maintained | Overweight | $21 $19 | May 7, 2026 |
| Baird | Maintained | Neutral | $17 $14 | May 7, 2026 |
| Canaccord Genuity | Maintained | Hold | $16 $15 | Dec 17, 2025 |
| UBS | Maintained | Neutral | $16.25 $16 | Nov 6, 2025 |
| Canaccord Genuity | Maintained | Hold | $14 $16 | Oct 10, 2025 |
| Needham | Reiterated | Hold | — | Oct 10, 2025 |
| Needham | Reiterated | Hold | — | Jul 30, 2025 |
| Barclays | Maintained | Overweight | $24 $21 | Jul 30, 2025 |
| Canaccord Genuity | Maintained | Hold | $15 | Jul 11, 2025 |
| Barclays | Maintained | Overweight | $29 $24 | Apr 30, 2025 |
| UBS | Maintained | Neutral | $19 $16.25 | Apr 29, 2025 |
| BTIG | Downgraded from Buy | Neutral | — | Apr 29, 2025 |
| Canaccord Genuity | Maintained | Hold | $17 $15 | Apr 29, 2025 |
| Needham | Reiterated | Hold | — | Apr 28, 2025 |
| Jefferies | Maintained | Hold | $16 $15 | Apr 14, 2025 |
| Needham | Reiterated | Hold | — | Apr 14, 2025 |
| Needham | Reiterated | Hold | — | Apr 9, 2025 |
| Barclays | Maintained | Overweight | $26 $29 | Feb 5, 2025 |
| Needham | Maintained | Hold | — | Feb 4, 2025 |
| Barclays | Maintained | Overweight | $27 $26 | Jan 9, 2025 |
| Needham | Reiterated | Hold | — | Oct 31, 2024 |
| Alliance Global Partners | Initiated | Buy | $20 | Oct 21, 2024 |
| BTIG | Initiated | Buy | $25 | Oct 17, 2024 |
| Barclays | Maintained | Overweight | $29 $27 | Oct 14, 2024 |
| Needham | Reiterated | Hold | — | Oct 10, 2024 |
4 filings from 4 insiders · 0 buy / 0 sell over 6m
Officers and directors of INMD, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| ITZKOVICH MOSHEChief Financial Officer | Grant | 14.0k | — | — | Aug 4, 2026 |
| NASS SHLOMODirector | Grant | 2.0k | — | — | Jul 30, 2026 |
| KENNETH NADAVDirector | Grant | 2.0k | — | — | Jul 30, 2026 |
| RON HADARDirector | Grant | 2.0k | — | — | Jul 30, 2026 |
No analyst notes on INMD yet.
Analyst Ratings
3 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 0 | 0 | 5 | 0 | 0 | Hold3.00 |
| 1 mo ago | 0 | 0 | 5 | 0 | 0 | Hold3.00 |
| 2 mo ago | 0 | 0 | 5 | 0 | 0 | Hold3.00 |